Facial hyperpigmentation during pegylated interferon alpha therapy for chronic hepatitis B infection

Acta Gastro-Enterologica Belgica

Volumn 74, Issue 1, 2011, Pages 103-104

  Dag, M S ^a   Aydinli, M ^a   Kazanci, U ^b   Kadayifci, A ^a  

^a Department of Gastroenterology ^*  (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; MELANIN; PEGINTERFERON ALPHA2A; VIRUS DNA;

ADULT; CASE REPORT; ELASTOSIS; FACIAL HYPERPIGMENTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HYPERPIGMENTATION; LABORATORY TEST; LETTER; LIVER BIOPSY; LIVER FIBROSIS; MALE; SKIN BIOPSY; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS LOAD;

ANTIVIRAL AGENTS; FACIAL DERMATOSES; HEPATITIS B, CHRONIC; HUMANS; HYPERPIGMENTATION; INTERFERON-ALPHA; MALE; MIDDLE AGED; RECOMBINANT PROTEINS;

EID: 79956281148     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. MISTRY N., SHAPERO J., CRAWFORD R.I. A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin. Can. J. Gastroenterol., 2009, 23: 677-683.
2. WILLEMS M., MUNTE K., VROLIJK J.M., DEN HOLLANDER J.C., BÖHM M., KEMMEREN M.H., DE MAN R.A., BROUWER J.T. Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection. Br. J. Dermatol., 2003, 149: 390-394.
3. GURGUTA C., KAUER C., BERGHOLZ U., FORMANN E., STEINDLMUNDA P., FERENCI P. Tongue and skin hyperpigmentation during PEGinterferonalpha/ribavirin therapy in dark-skinned non-Caucasian patients with chronic hepatitis C. Am. J. Gastroenterol., 2006, 101: 197-198.
4. SOOD A., MIDHA V., BANSAL M., GOYAL A., SHARMA N. Lingual hyperpigmentation with pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. Indian J. Gastroenterol., 2006, 25: 324.
5. TORRES H.A., BULL L., ARDUINO R.C., BARNETT B.J. Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy. Am. J. Gastroenterol., 2007, 102: 1334-1335.
6. LIN J., LOTT J.P., AMOROSA V.K., KOVARIK C.L. Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin. J. Am. Acad. Dermatol., 2009, 60: 882-883.
7. FERNÁNDEZ A., VÁZQUEZ S., RODRÍGUEZ-GONZÁLEZ L. Tongue hyperpigmentation resulting from peginterferon alpha-2a and ribavirin treatment in a Caucasian patient with chronic hepatitis C. J. Eur. Acad. Dermatol. Venereol., 2008, 22: 1389-1391.
8. BIGBY M., STERN R.S., ARNDT K.A. Allergic cutaneous reactions to drugs. Prim. Care, 1989, 16: 713-727.
9. KAMEYAMA K., TANAKA S., ISHIDA Y., HEARING V.J. Interferons modulate the expression of hormone receptors on the surface of murine melanoma cells. J. Clin. Invest., 1989, 83: 213-221.
10. STRYJEK-KAMINSKA D., OCHSENDORF F., RÖDER C., WOLTER M., ZEUZEM S. Photoallergic skin reaction to ribavirin. Am. J. Gastroenterol., 1999, 94: 1686-1688.